Exceptionally Potent Anti-Tumor Bystander Activity of an scFv:sTRAIL Fusion Protein with Specificity for EGP2 Toward Target Antigen-Negative Tumor Cells-Reference-Cited by-同舟云学术

Exceptionally Potent Anti-Tumor Bystander Activity of an scFv:sTRAIL Fusion Protein with Specificity for EGP2 Toward Target Antigen-Negative Tumor Cells

Published:2004-09 Issue:5 Volume:6 Page:636-645
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Bremer Edwin,Samplonius Douwe,Kroesen Bart-Jan,van Genne Linda,de Leij Lou,Helfrich Wijnand

Publisher

Elsevier BV

Subject

Cancer Research

Reference46 articles.

1. Treatment of relapsed CD20` Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group;Rehwald;Blood,2003

2. Safety and activity of docetaxel and trastuzumab in HER2 overexpressing metastatic breast cancer: a pilot phase II study;Montemurro;Am J Clin Oncol,2003

3. Radioiodinated (I-125) monoclonal antibody 425 in the treatment of high grade glioma patients: ten-year synopsis of a novel treatment;Emrich;Am J Clin Oncol,2002

4. Incidence and nature of CD20-negative relapses following rituximab therapy in aggressive B-cell non-Hodgkin's lymphoma: a retrospective review;Kennedy;Br J Haematol,2002

5. Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression;Davis;Clin Cancer Res,1999

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo;Journal of Clinical Medicine;2021-06-15

2. A novel human monoclonal antibody specific to the A33 glycoprotein recognizes colorectal cancer and inhibits metastasis;mAbs;2020-01-01

3. A novel human monoclonal antibody specific to the A33 glycoprotein recognizes colorectal cancer and inhibits metastasis;2019-08-28

4. Molecular Mode of Action of TRAIL Receptor Agonists—Common Principles and Their Translational Exploitation;Cancers;2019-07-07

5. An Enzyme-Directed Imidazoquinoline Activated by Drug Resistance;Biochemistry;2018-03-19